Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Manufactured under strict quality control and high purity standards
Receptor Pathway Comparison This dual incretin research peptide shares the same receptor targets (GLP-1R + GIPR) as Tirzepatide (LY3298176), the FDA-approved twincretin compound studied extensively in metabolic research
Provides an antioxidant
Research Summary Teichman et al
Some users notice changes in other areas too: Eyebrows and eyelashes may appear darker and more defined
Another case had a better response because deep vaporization was safer given the diameter of the lesion (4 mm)
US$ 25.74
US$ 27.36
US$ 24.81
US$ 23.25
